heart failure

Eli Lilly, Boehringer Ingelheim's Jardiance turns up heat on AstraZeneca's Farxiga with broad EU heart failure approval

Fierce Pharma

Mon, 03/7/22 - 10:10 am

Eli Lilly

Boehringer Ingelheim

Jardiance

heart failure

Europe

AstraZeneca

Farxiga

Eli Lilly, Boehringer Ingelheim's Jardiance clinches heart failure edge with FDA nod for wider label

Fierce Pharma

Fri, 02/25/22 - 10:24 am

How Abbott’s Newest Indication Is Reshaping Heart Failure Management

Medical Devices and Diagnostics Industry

Thu, 02/24/22 - 10:58 pm

Taking on Big Pharma-sized indications, tiny biotech claims early win in fat loss. Will it translate to diabetes, NASH and beyond?

Endpoints

Wed, 02/9/22 - 10:01 am

Rivus Pharmaceuticals

diabetes

NASH

heart failure

Cytokinetics hopes to resurrect omecamtiv

EP Vantage

Wed, 01/19/22 - 11:08 am

Cytokinetics

Omecamtiv Mecarbil

heart failure

Abandoned by Amgen, Cytokinetics lands $50M upfront deal for Chinese rights to heart failure prospect

Fierce Biotech

Tue, 12/21/21 - 10:34 am

Ji Xing Pharmaceuticals

Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?

Motley Fool

Sun, 12/5/21 - 10:47 pm

Moderna, AstraZeneca announce positive AZD8601 data from Phase 2 study in heart failure

Seeking Alpha

Mon, 11/15/21 - 12:27 pm

J&J looks to toss its SGLT2 hat in the ring for two types of heart failure

Endpoints

Sun, 11/14/21 - 10:47 pm

Boehringer-Lilly’s Jardiance obtains FDA priority review to treat heart failure

Pharmaceutical Business Review

Fri, 11/12/21 - 10:37 am

Heart Failure Patients Take Heart as Carmat’s Bioprosthetic Implanted into First Woman

BioSpace

Thu, 09/23/21 - 11:00 am

Abbott seeks expanded indication, national coverage for CardioMEMS device

MedCity News

Sat, 09/18/21 - 08:19 pm

COVID-19 seems to skew Abbott heart failure monitor study results

Medtech Dive

Mon, 08/30/21 - 11:45 pm

Study Data Show Abbott's CardioMEMSDevice Can Improve Care for More Patients with Heart Failure

Drugs.com

Sun, 08/29/21 - 11:19 pm

Here's What This Label Expansion Could Mean for Eli Lilly Investors

Motley Fool

Sun, 08/29/21 - 11:16 pm

Bristol-backed Cardior gets $75M to run midphase antisense heart failure trial

Fierce Biotech

Wed, 08/25/21 - 11:15 am

Eli Lilly, Boehringer Ingelheim tout pivotal heart failure win for Jardiance, potentially setting up a Novartis showdown

Endpoints

Tue, 07/6/21 - 10:52 am

AZ drug for hard-to-treat heart failure has mixed results in trial

Pharmaforum

Fri, 07/2/21 - 10:59 am

Farxiga faces first heart failure rival as EU OKs Boehringer/Lilly’s Jardiance

Pharmaforum

Wed, 06/23/21 - 10:59 am

Fresh off $598M deal with Novo Nordisk, a Japanese stem cell company is on its way to the clinic with a different approach to treating heart failure

Endpoints

Fri, 06/11/21 - 10:56 am

Search form

You are here

heart failure

Pages